Patents by Inventor Harri Sihto

Harri Sihto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions comprising phosphodiesterase inhibitors for use in the treatment of a solid tumor in a human patient
    Patent number: 9901579
    Abstract: The present invention is related to a composition comprising a phosphodiesterase inhibitor, such as anagrelide or a salt thereof, for use in the treatment of a solid tumor, such as gastrointestinal stromal tumor (GIST) or a liposarcoma, which express phosphodiesterase 3 enzymes, in a human patient.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: February 27, 2018
    Assignee: Sartar Therapeutics Ltd
    Inventors: Harri Sihto, Olli-Pekka Pulkka, Olli Kallioniemi, Heikki Joensuu
  • Compositions comprising phosphodiesterase inhibitors for use in the treatment of a solid tumor in a human patient
    Publication number: 20160354376
    Abstract: The present invention is related to a composition comprising a phosphodiesterase inhibitor, such as anagrelide or a salt thereof, for use in the treatment of a solid tumor, such as gastrointestinal stromal tumor (GIST) or a liposarcoma, which express phosphodiesterase 3 enzymes, in a human patient.
    Type: Application
    Filed: October 17, 2014
    Publication date: December 8, 2016
    Inventors: Harri Sihto, Olli-Pekka Pulkka, Olli Kallioniemi, Heikki Joensuu